IN VITRO CELL QUALITY OF ATREUS® 3C DERIVED PLATELET CONCENTRATES TREATED WITH THE MIRASOL® PATHOGEN REDUCTION TECHNOLOGY SYSTEM

被引：0
|
作者：
Maia, S. [1 ]
Ramoa, A. [1 ]
Pacheco, R. [1 ]
Ruivo, I [1 ]
van Waeg, G. [2 ]
机构：
[1] Ctr Reg Sangue Porto, Oporto, Portugal
[2] CaridianBCT, Zaventem, Belgium
来源：
VOX SANGUINIS | 2010年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：245 / 245
页数：1
相关论文
共 50 条
  • [41] Evaluation of fibrin sealant prepared from MIRASOL® Pathogen Reduction Technology treated plasma using the CRYOSEAL® FS-system
    Kumar, V.
    Paglinawan, M.
    Buytaert-Hoefen, Kimberley
    Bihm, D.
    Hendrix, B.
    Goodrich, R.
    Chapman, J.
    Miklauz, M.
    [J]. TRANSFUSION, 2008, 48 (02) : 143A - 143A
  • [42] Platelet concentrates produced from whole blood held at ambient temperature overnight and processed on the Gambro BCT Atreus 2C+ system - In vitro quality assessment
    Thomas, S.
    Beard, M.
    Garwood, M.
    Callaert, M.
    van Waeg, G.
    Cardigan, R. A.
    [J]. VOX SANGUINIS, 2008, 95 : 322 - 322
  • [43] In vitro quality of platelet concentrates from pooled buffy-coats made of fresh and overnight stored WB processed on the novel atreus 2c+system
    Sandgren, P.
    Gulliksson, H.
    Callaert, M.
    [J]. TRANSFUSION, 2007, 47 (03) : 3A - 4A
  • [44] Analysis of Plasma Treated with Mirasol® Pathogen Reduction Technology and Stored up to Two Years at Variable Temperatures (-18°C AND-30°C)
    Miklauz, M. M.
    Larrea, L.
    Scheel, E.
    Smith, J. W.
    Marschner, S.
    Goodrich, R. P.
    [J]. TRANSFUSION, 2011, 51 : 44A - 45A
  • [45] IN VITRO QUALITY TEST OF PLATELET CONCENTRATES FROM BUFFY COAT AND APHERESIS IN ADDITIVE SOLUTION, TREATED WITH TWO PATHOGEN INACTIVATION SYSTEMS
    Castrillo, A.
    Arcas, C.
    Castro, A.
    Eiras, A.
    Adelantado, M.
    Areal, C.
    Rodriguez, M., I
    [J]. VOX SANGUINIS, 2010, 99 : 249 - 250
  • [46] Should the Use of Pathogen Inactivated Platelet Concentrates Be Extended to 7 Days? In Vitro Study on the Quality of Platelets at 3, 5 and 7 Days
    Agliastro, R. E.
    DeFrancisci, G.
    Diquattro, M.
    Bonaccorso, R.
    Tagliavia, M.
    Marcatti, M.
    Palma, B.
    [J]. TRANSFUSION, 2009, 49 : 96A - 97A
  • [47] In vitro evaluation of Haemonetics MCS plus apheresis platelet concentrates treated with photochemical pathogen inactivation following plasma volume reduction using the INTERCEPT Preparation Set
    Isola, H
    Kientz, D
    Aleil, B
    Laeuffer, P
    Weil, J
    Wiesel, ML
    Laforêt, M
    Lin, L
    Mayaudon, V
    Cazenave, JP
    [J]. VOX SANGUINIS, 2006, 90 (02) : 128 - 130
  • [48] Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study
    Picker, Susanne M.
    Steisel, Alexander
    Gathof, Birgit S.
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2009, 40 (02) : 79 - 85
  • [49] Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study
    Sandgren, Per
    Callaert, Martine
    Shanwell, Agneta
    Gulliksson, Hans
    [J]. TRANSFUSION, 2008, 48 (04) : 688 - 696
  • [50] Generation of neutrophil priming activity by cell-containing blood components treated with pathogen reduction technology and stored in platelet additive solutions
    Ambruso, Daniel R.
    Thurman, Gail
    Tran, Khoa
    Marschner, Susanne
    Gathof, Birgit
    Janetzko, Karin
    Goodrich, Raymond P.
    [J]. TRANSFUSION, 2011, 51 (06) : 1220 - 1227
12345